naphthalenediimide has been researched along with gemcitabine in 1 studies
| Studies (naphthalenediimide) | Trials (naphthalenediimide) | Recent Studies (post-2010) (naphthalenediimide) | Studies (gemcitabine) | Trials (gemcitabine) | Recent Studies (post-2010) (gemcitabine) |
|---|---|---|---|---|---|
| 231 | 0 | 177 | 12,523 | 3,208 | 6,923 |
| Protein | Taxonomy | naphthalenediimide (IC50) | gemcitabine (IC50) |
|---|---|---|---|
| Chain A, DEOXYNUCLEOSIDE KINASE | Drosophila melanogaster (fruit fly) | 0.76 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AA; Marchetti, C; Neidle, S; Ohnmacht, SA | 1 |
1 other study(ies) available for naphthalenediimide and gemcitabine
| Article | Year |
|---|---|
A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; G-Quadruplexes; Gemcitabine; Gene Expression Profiling; Humans; Imides; Ligands; Naphthalenes; Pancreatic Neoplasms; Repressor Proteins; Up-Regulation | 2020 |